In the subset of normal karyotype AML with NPM1 mutations Garzon et al. were able to demonstrate that a significant proportion of patients have an up-regulation of microRNA 10a (miR-10a) in their leukemic cells [22]. This evidence concerns the gene NPM1 and acute myeloid leukemia.